Cure8 research brief
Why This Matters
Depressive disorders—diagnosed using structured clinical interviews—appear to be relatively common in people with IBD, which has implications for screening and referral to mental health care within IBD clinics.
Who Should Pay Attention
Adults with IBD, gastroenterologists, mental health clinicians working with IBD patients, and researchers on psychiatric comorbidity in IBD.
Study Snapshot
What To Know
This study pooled data from 12 independent studies (13 reports; 1,159 patients across 10 countries) that used structured or semi‑structured clinical interviews to diagnose depressive disorders in people with IBD.
The primary outcome was current MDD; secondary outcomes included current dysthymia, any current depressive disorder, and any lifetime depressive disorder. Current MDD prevalence was pooled at 13% (95% CI 4%–32%), dysthymia 4%, any current depressive disorder 18%, and any lifetime depressive disorder 30%.
The review did not find consistent differences in depressive disorder prevalence between Crohn's disease and ulcerative colitis. The authors caution that estimates are limited by the small number of studies and high between‑study heterogeneity.
Keep In Mind
Findings are drawn from a meta‑analysis of a small number of studies with substantial between‑study heterogeneity; prevalence estimates should be interpreted cautiously. This summary is grounded in the article abstract and not a review of full study reports.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.